NCT03055130

Brief Summary

The associations between female inflammatory bowel disease (IBD) patients and human papilloma virus (HPV) infection and cervical neoplasia (dysplasia or cancer) were unclear. Especially there was no data for Chinese IBD population. So we investigated the incidence and risk factors of HPV infection and cervical neoplasia (dysplasia or cancer) in female IBD patient.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

February 8, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 16, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

February 16, 2017

Status Verified

February 1, 2017

Enrollment Period

1.8 years

First QC Date

February 8, 2017

Last Update Submit

February 15, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • The different infection rate of HPV between controls and patients by detecting HPV-DNA using reverse dot-blot method.

    The difference of infection rate of HPV between healthy control and IBD patients was not clear.We are detecting HPV-DNA by reverse dot-blot and calculate the positive rate of HPV infection among controls and patients.

    July 2015 to July 2017

  • The different incidence of cervical neoplasm between controls and patients by performing Thinprep Cytology Test

    The difference of the incidence of cervical neoplasm between healthy control and IBD patients was not clear.All the controls and patients are going to perform Thinprep Cytology Test which could detect intraepithelial neoplasia of cervix.

    July 2015 to July 2017

Secondary Outcomes (1)

  • Find drugs relating to HPV infection of IBD patients

    July 2015 to July 2017

Study Arms (2)

Case group

Female IBD patients who had sexual life between 21-60 years-old were recruited.

Other: Thinprep Cytology Test (TCT) and HPV infection types were tested by gynecologist

control group

Female people who perform physical examination in our hospital between 21-60 years-old were recruited as control during the study period.

Other: Thinprep Cytology Test (TCT) and HPV infection types were tested by gynecologist

Interventions

Eligibility Criteria

Age20 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

All consecutive female adult patients betwween 20-60 year old were recruited from July 2015 to July 2017. Female persons who performed physical examination in our hospital with the same age were recuited as control. All of the received HPV DNA testing and TCT. The case and control were matched 1:3

You may qualify if:

  • between 20-60 years old;
  • Patients diagnosed as IBD according to previously established international criteria

You may not qualify if:

  • \. Patients refuse to participating

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gastroenterology

Guangzhou, Guangdong, 510000, China

RECRUITING

MeSH Terms

Conditions

Inflammatory Bowel DiseasesUterine Cervical Neoplasms

Interventions

Thrombin Time

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesUterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

Blood Coagulation TestsHematologic TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesBlood Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Xiang Gao, PhD

    The sixth affiated hospital of Sun-Yat sen University

    STUDY DIRECTOR

Central Study Contacts

Qingfan Yang, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 8, 2017

First Posted

February 16, 2017

Study Start

July 1, 2015

Primary Completion

May 1, 2017

Study Completion

July 1, 2017

Last Updated

February 16, 2017

Record last verified: 2017-02

Locations